Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era?-Reference-Cited by-同舟云学术

Is Memorial Sloan-Kettering Cancer Center risk classification appropriate for Japanese patients with metastatic renal cell carcinoma in the cytokine era?

Published:2013-10 Issue:7 Volume:31 Page:1276-1282
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Shinohara Nobuo,Abe Takashige,Mochizuki Tango,Kashiwagi Akira,Kanagawa Kouichi,Maruyama Satoru,Sazawa Ataru,Oba Koji,Nonomura Katsuya

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference18 articles.

1. Interferon-α and survival in metastatic renal carcinoma: Early results of a randomized controlled trial;Lancet,1999

2. NCCN task force report: Optimizing treatment of advanced renal cell carcinoma with molecular targeted therapy;Hudes;J Natl Compr Canc Netw,2011

3. Interferon-α as a comparative treatment for clinical trials of new therapies against advanced renal cell carcinoma;Motzer;J Clin Oncol,2002

4. Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinoma;Mekhail;J Clin Oncol,2005

5. Overall survival and updated results from a phase II study of sunitinib in Japanese patients with metastatic renal cell carcinoma;Tomita;Jpn J Clin Oncol,2010

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluating the Prognostic Variables for Overall Survival in Patients with Metastatic Renal Cell Carcinoma: A Meta-Analysis Of 29,366 Patients;JU Open Plus;2024-04

2. Predictive Impact of Early Changes in Serum C-Reactive Protein Levels in Nivolumab Plus Ipilimumab Therapy for Metastatic Renal Cell Carcinoma;Clinical Genitourinary Cancer;2022-02

3. The prognostic value of galactosylceramide-sulfotransferase (Gal3ST1) in human renal cell carcinoma;Scientific Reports;2021-05-25

4. Prognostic role of pretreatment lactate dehydrogenase in patients with metastatic renal cell carcinoma: A systematic review and meta-analysis;International Journal of Surgery;2020-07

5. Predictive impact of an early change in serum C-reactive protein levels in nivolumab therapy for metastatic renal cell carcinoma;Urologic Oncology: Seminars and Original Investigations;2020-05